SELEQT-HF - H4D Interventie
SELEnium and coQ10 Treatment for Heart Failure (SELEQT-HF); A randomized, double-blind, multicentre study in patients with chronic heart failure.
- Stage
- inclusie
- Medicine
- Selenium en Co-enzym Q10
- Population
- Hartfalen
- Phase
- IV
- First Patient In
- 12 May 2026
- Last Patient In
- 1 May 2028
- Last Patient Last Visit
- 1 May 2030
Inclusion period, 700 days remaining
National Lead
dr. P van der Meer
Cardioloog
Study Director
dr. J. Schaap
Cardioloog
Office Contact
